UBESLO
Dead / Abandoned — Abandoned — no statement of use filed (as of 26 Jan 2026)
What this means for you
This application is over — abandoned 26 Jan 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98726200
- Mark type
- Stylized text
- Filed
- 30 Aug 2024
- Published for opposition
- 29 Apr 2025
- Abandoned
- 26 Jan 2026
- Attorney of record
- Michelle Rosenberg
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for lowering cholesterol; pharmaceuticals, namely, lipid lowering agents; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders, major adverse cardiac events, cholesterol-related diseases and disorders, dyslipidemia, lipid-related diseases and disorders, diabetes, age-related macular degeneration, neurodegenerative diseases and disorders, dementia, Lewy body dementia, and Alzheimer's disease
Owner
- NewAmsterdam Pharma B.V., Naarden, NL
- NewAmsterdam Pharma B.V., Naarden, NL
Prosecution history
- 26 Jan 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 26 Jan 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 24 Jun 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 29 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Apr 2025 — PUBLISHED FOR OPPOSITION
- 23 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Apr 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 21 Mar 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 21 Mar 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 21 Mar 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 08 Mar 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 08 Mar 2025 — NON-FINAL ACTION E-MAILED
- 08 Mar 2025 — NON-FINAL ACTION WRITTEN
- 05 Mar 2025 — ASSIGNED TO EXAMINER
- 30 Aug 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED